Drugs / Tc-99m Pertechnetate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01437254 Comparator | Oct 2011 → Apr 2012 | thyroid tumor | AHS Cancer Control Alberta | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tc-99m Pertechnetate | “Patients who have had a thyroidectomy for cancer routinely have a Tc-99m Pertechnetate (GPERT) scan at the Cross Cancer Institute” NCT01437254 ↗ |
| Known as | GPERT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01437254 ↗ |
| Modality | Diagnostic / imaging agent | “Patients who have had a thyroidectomy for cancer routinely have a Tc-99m Pertechnetate (GPERT) scan at the Cross Cancer Institute” NCT01437254 ↗ |